Additionally, a trend has been observed linking RANKL expression to a more favorable prognosis for OS, suggesting that the RANKL/OPG pathway may play a crucial role in risk prediction for breast cancer patients. The gene discussed is TNFSF11; the disease is breast carcinoma.